Top Institutional Investors

Blue Owl Capital Holdings LP — 13F Holdings & Portfolio

CIK 1858703 · latest 13F-HR filed 2026-08-11

Backtest portfolio

Blue Owl Capital Holdings LP manages $664.5M in 13F-reported U.S. long-equity assets across 76 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPCX (35.97%), AKTS (14.89%), CGEM (4.22%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 18 new positions and exited 22; 19 existing positions rose in reported value and 23 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$664.5M

Long-equity book

Holdings
76

Distinct positions

Period
2026-06-30

Filed 2026-08-11

Q/Q Activity
+18 / −22 / ↑19 / ↓23

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26
SPCX36.3% · newAKTS15.0% · -3%CGEM4.3% · -19%LRMR4.2% · +13%NCDL4.0% · 0%MPLT4.0% · -27%COF3.7% · newOBDC3.4% · 0%FISN2.2% · newDELL2.2% · +137%HLLY1.7% · +3%EYPT1.7% · -16%SGMT1.5% · +278%CRVS1.4% · +12%ARTV1.3% · newCMPX1.2% · +8%CNDT1.1% · 0%RYTM1.0% · 0%CMPS1.0% · -75%RARE0.9% · -40%PVLA0.8% · +16%IMA0.8% · -4%VRDN0.7% · newIMMX0.7% · -20%ORIC0.7% · +167%LENZ0.7% · +49%AQST0.6% · -30%STWD0.5% · +24%EVMN0.4% · +80%ELDN0.3% · -60%CABA0.3% · newCHYM0.3% · newCNTX0.2% · -42%WW0.2% · -12%MRKR0.1% · 0%ADCT0.1% · 0%HELP0.1% · newFLD0.1% · 0%NIOBW0.1% · -16%RZLVW0.0% · 0%BNAIW0.0% · -13%PIPR0.0% · 0%ENGNW0.0% · -90%CELC0.0% · newUSDEW0.0% · newET0.0% · 0%CAI0.0% · 0%VOD0.0% · 0%DAVEW0.0% · 0%MRNO0.0% · newAMODW0.0% · 0%RDZNW0.0% · 0%AMOD0.0% · -98%AEON0.0% · 0%SLND.WS0.0% · 0%BGLWW0.0% · 0%SHFS0.0% · 0%BKSY0.0% · newTVGNW0.0% · 0%ZEOWW0.0% · new

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

3 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 79.3%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People
Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Blue Owl Capital Holdings LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 SPACE EXPLORATION TECHN CORP SPCX 84615Q103 $239.0M 35.97% 1,398,815 SH
2 AKTIS ONCOLOGY INC AKTS 01021M104 $99.0M 14.89% 3,070,219 SH
3 CULLINAN THERAPEUTICS INC CGEM 230031106 $28.0M 4.22% 1,539,764 SH
4 LARIMAR THERAPEUTICS INC LRMR 517125100 $27.9M 4.21% 9,163,157 SH
5 NUVEEN CHURCHILL DIRECT LEND NCDL 67090S108 $26.6M 4.01% 2,143,626 SH
6 MAPLIGHT THERAPEUTICS INC MPLT 56565P103 $26.2M 3.94% 729,929 SH
7 CAPITAL ONE FINL CORP COF 14040H105 $24.0M 3.62% 119,757 SH
8 BLUE OWL CAPITAL CORPORATION OBDC 69121K104 $22.2M 3.35% 2,045,070 SH
9 DEEP FISSION INC FISN 243927100 $14.7M 2.22% 1,333,333 SH
10 DELL TECHNOLOGIES INC DELL 24703L202 $14.2M 2.14% 32,961 SH
11 HOLLEY INC HLLY 43538H103 $11.2M 1.68% 4,376,888 SH
12 EYEPOINT INC EYPT 30233G209 $10.9M 1.64% 762,594 SH
13 SAGIMET BIOSCIENCES INC SGMT 786700104 $9.7M 1.47% 1,260,544 SH
14 CORVUS PHARMACEUTICALS INC CRVS 221015100 $9.1M 1.37% 608,600 SH
15 ARTIVA BIOTHERAPEUTICS INC ARTV 04317A107 $8.5M 1.28% 874,542 SH
16 COMPASS THERAPEUTICS INC CMPX 20454B104 $7.9M 1.19% 3,624,076 SH
17 CONDUENT INC CNDT 206787103 $7.4M 1.11% 5,036,595 SH
18 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $6.8M 1.03% 61,455 SH
19 COMPASS PATHWAYS PLC CMPS 20451W101 $6.4M 0.96% 450,000 SH
20 ULTRAGENYX PHARMACEUTICAL IN RARE 90400D108 $6.1M 0.92% 182,638 SH
21 PALVELLA THERAPEUTICS INC NE PVLA 697947109 $5.5M 0.83% 36,259 SH
22 IMAGENEBIO INC IMA 45175G207 $5.4M 0.81% 917,692 SH
23 COMPASS PATHWAYS PLC Call CMPS 20451W901 $5.2M 0.78% 1,670,500 SH
24 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $4.8M 0.72% 260,000 SH
25 IMMIX BIOPHARMA INC IMMX 45258H106 $4.5M 0.68% 437,552 SH
26 ORIC PHARMACEUTICALS INC ORIC 68622P109 $4.3M 0.65% 400,000 SH
27 LENZ THERAPEUTICS INC LENZ 52635N103 $4.3M 0.65% 756,722 SH
28 AQUESTIVE THERAPEUTICS INC AQST 03843E104 $3.9M 0.59% 942,932 SH
29 STARWOOD PPTY TR INC STWD 85571B105 $3.2M 0.48% 196,355 SH
30 EVOMMUNE INC EVMN 30054Y107 $2.4M 0.36% 180,000 SH
31 ELEDON PHARMACEUTICALS INC ELDN 28617K101 $2.2M 0.34% 566,509 SH
32 CABALETTA BIO INC CABA 12674W109 $2.2M 0.33% 714,710 SH
33 CHIME FINL INC CHYM 16935C109 $1.8M 0.28% 89,878 SH
34 CONTEXT THERAPEUTICS INC CNTX 21077P108 $1.6M 0.24% 2,934,015 SH
35 WW INTL INC WW 98262P200 $1.3M 0.20% 84,399 SH
36 MARKER THERAPEUTICS INC MRKR 57055L206 $814.7K 0.12% 554,250 SH
37 ERASCA INC Call ERAS 29479A908 $795.0K 0.12% 100,000 SH
38 ADC THERAPEUTICS SA ADCT H0036K147 $784.9K 0.12% 733,568 SH
39 CYBIN INC HELP 23256X407 $396.0K 0.06% 59,911 SH
40 FOLD HLDGS INC FLD 29103K100 $385.5K 0.06% 856,632 SH
41 NIOCORP DEVS LTD NIOBW 654484153 $381.0K 0.06% 268,280 SH
42 ELEDON PHARMACEUTICALS INC Call ELDN 28617K901 $285.0K 0.04% 200,000 SH
43 REZOLVE AI PLC RZLVW G75398118 $214.0K 0.03% 235,121 SH
44 BRAND ENGAGEMENT NETWORK INC BNAIW 104932116 $203.5K 0.03% 1,453,808 SH
45 PIPER SANDLER COMPANIES PIPR 724078209 $175.6K 0.03% 2,428 SH
46 ENGENE THERAPEUTICS INC ENGNW 29286X119 $148.2K 0.02% 511,177 SH
47 LARIMAR THERAPEUTICS INC Call LRMR 517125900 $145.7K 0.02% 728,600 SH
48 CELCUITY INC CELC 15102K100 $130.7K 0.02% 1,249 SH
49 COMPASS THERAPEUTICS INC Call CMPX 20454B904 $106.3K 0.02% 303,800 SH
50 STABLECOINX INC USDEW 85238K118 $102.5K 0.02% 250,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-11 $664.5M 76 0001193125-26-345031
2026-03-31 2026-05-14 $372.2M 76 0001193125-26-223563
2025-12-31 2026-02-20 $324.0M 82 0001193125-26-061298
2025-12-31 2026-02-09 $1.34B 83 0001193125-26-042263
Filer Information
Address
399 PARK AVENUE
NEW YORK, NY 10022
Phone
(212) 287-6787
Filing Manager
Blue Owl Capital Holdings LP
New York, NY
Signatory
Karen Hager
Chief Compliance Officer